These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7076201)

  • 1. Interobserver variation in the identification of breast carcinoma in intramammary lymphatics.
    Gilchrist KW; Gould VE; Hirschl S; Imbriglia JE; Patchefsky AS; Penner DW; Pickren J; Schwartz IS; Wheeler JE; Barnes JM; Mansour EG
    Hum Pathol; 1982 Feb; 13(2):170-2. PubMed ID: 7076201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell emboli in the pectoral lymphatics of patients with breast cancer.
    Nakao K; Miyata M; Aono T; Ogino N; Tsumori T; Kawashima Y
    Jpn J Surg; 1989 Jul; 19(4):392-7. PubMed ID: 2810952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatics.
    Orbo A; Stalsberg H; Kunde D
    Cancer; 1990 Sep; 66(5):972-7. PubMed ID: 2167149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic and blood vessel invasion in breast carcinoma: a useful prognostic indicator?
    Lee AK; DeLellis RA; Silverman ML; Wolfe HJ
    Hum Pathol; 1986 Oct; 17(10):984-7. PubMed ID: 3759068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramammary lymphatic invasion in breast carcinomas. Evaluation using ABH isoantigens as endothelial markers.
    Lee AK; DeLellis RA; Wolfe HJ
    Am J Surg Pathol; 1986 Sep; 10(9):589-94. PubMed ID: 2428260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
    Williams CS; Leek RD; Robson AM; Banerji S; Prevo R; Harris AL; Jackson DG
    J Pathol; 2003 Jun; 200(2):195-206. PubMed ID: 12754740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast.
    Lee AK; DeLellis RA; Silverman ML; Heatley GJ; Wolfe HJ
    J Clin Oncol; 1990 Sep; 8(9):1457-65. PubMed ID: 2202788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0).
    Leitner SP; Swern AS; Weinberger D; Duncan LJ; Hutter RV
    Cancer; 1995 Dec; 76(11):2266-74. PubMed ID: 8635031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of immunohistochemical stains to identify endothelial-lined channels in mammary carcinoma.
    Saigo PE; Rosen PP
    Cancer; 1987 Jan; 59(1):51-4. PubMed ID: 2431757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease.
    Rabban JT; Glidden D; Kwan ML; Chen YY
    Am J Surg Pathol; 2009 Feb; 33(2):256-63. PubMed ID: 18936689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of E-cadherins in development of lymphatic tumor emboli.
    Gupta A; Deshpande CG; Badve S
    Cancer; 2003 May; 97(9):2341-7. PubMed ID: 12712492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemistry in the identification of vascular invasion in breast cancer.
    Bettelheim R; Mitchell D; Gusterson BA
    J Clin Pathol; 1984 Apr; 37(4):364-6. PubMed ID: 6200505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance.
    Rosen PP
    Pathol Annu; 1983; 18 Pt 2():215-32. PubMed ID: 6674861
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications.
    Mohammed RA; Ellis IO; Elsheikh S; Paish EC; Martin SG
    Breast Cancer Res Treat; 2009 Jan; 113(2):261-73. PubMed ID: 18293084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of lymphangiogenesis during breast carcinogenesis.
    Vleugel MM; Bos R; van der Groep P; Greijer AE; Shvarts A; Stel HV; van der Wall E; van Diest PJ
    J Clin Pathol; 2004 Jul; 57(7):746-51. PubMed ID: 15220369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pre-lymphatic pathway, the rooths of the lymphatic system in breast tissue: a 3D study.
    Asioli S; Eusebi V; Gaetano L; Losi L; Bussolati G
    Virchows Arch; 2008 Oct; 453(4):401-6. PubMed ID: 18769937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological correlation of cutaneous metastatic breast carcinoma using lymphatic and vascular markers: lymphatics are mainly involved in cutaneous metastasis.
    Yun SJ; Park HY; Lee JS; Park MH; Lee JB; Won YH
    Clin Exp Dermatol; 2012 Oct; 37(7):744-8. PubMed ID: 22329727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements.
    Faverly DR; Hendriks JH; Holland R
    Cancer; 2001 Feb; 91(4):647-59. PubMed ID: 11241230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramammary lymph nodes.
    Jadusingh IH
    J Clin Pathol; 1992 Nov; 45(11):1023-6. PubMed ID: 1452776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer pathology practices among Medicare patients undergoing unilateral extended simple mastectomy.
    Imperato PJ; Waisman J; Wallen M; Llewellyn CC; Pryor V
    J Womens Health Gend Based Med; 2002; 11(6):537-47. PubMed ID: 12225627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.